Results 181 to 190 of about 4,877,471 (249)

Prognostic significance of LOXL2 enzyme activity in primary myelofibrosis. [PDF]

Medicine (Baltimore)
Lv G, Lv W.
europepmc   +1 more source

Glutathione reductase and nitroblue tetrazolium reduction deficiencies in neutrophils of patients with primary idiopathic myelofibrosis.

, 1984
Axel Périanin, M T Labro-Bryskier, Claude Marquetty, J Hakim   +3 more
openalex   +1 more source

Periportal extramedullary hematopoiesis in a patient with primary myelofibrosis: A great mimicker of an infiltrating tumor in the liver. [PDF]

Radiol Case Rep
Crawford CK, Arshad H, Kawamoto S, Fishman EK.   +3 more
europepmc   +1 more source

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival. [PDF]

Blood Adv, 2023
Gangat N, Kuykendall A, Al Ali N, Goel S, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar A, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Komrokji R, Tefferi A.   +15 more
europepmc   +1 more source

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Multiple Aneurysms and Thrombotic Events as Initial Manifestations of Primary Myelofibrosis: A Case Report. [PDF]

Cureus
Manganas K, Bemplidakis T, Papachristou K, Angelara M, Karamanakos G.   +4 more
europepmc   +1 more source

DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies. [PDF]

Clin Epigenetics
Dursun Torlak E, Tharmapalan V, Kricheldorf K, Schifflers J, Caduc M, Zenke M, Koschmieder S, Wagner W.   +7 more
europepmc   +1 more source

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice. [PDF]

EJHaem, 2023
Amé S, Barraco F, Ianotto JC, Jourdan E, Rey J, Viallard JF, Wémeau M, Kiladjian JJ.   +7 more
europepmc   +1 more source

Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry. [PDF]

Hemasphere
Guglielmelli P, Ghirardi A, Carobbio A, Masciulli A, Morrone L, Mora B, Rumi E, Triguero A, Finazzi MC, Pettersson H, Boldrini V, Vanni D, Rambaldi A, Passamonti F, Alvarez-Larràn A, Andreasson B, Vannucchi AM, Barbui T.   +17 more
europepmc   +1 more source

Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study

Olga Vinogradova, M. M. Pankraskina, А. Л. Неверова, Д. И. Шихбабаева, M. A. Murzabekova, M. V. Chernikov, A. G. Popova, В. П. Косенкова, L. B. Egoryan, В. В. Птушкин   +9 more
openalex   +1 more source